Ledger.Open graph →
SEC Form D · Amendment · filed September 18, 2019

ECM Therapeutics, Inc

Offering
$10.0M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WARRENDALE, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Jami S. O'Toole · Cambridge, MAExec · DirectorPeter Birch · Chatham, Ontario, CanadaExecErin S. Osborn · Cambridge, MAExec · DirectorStephen S. Ramsthaler · New York, NYExecVinay S. Mohta · Cambridge, MAExecEdward S. Rayner · Cambridge, MAExec · DirectorGrady Collins · Austin, TXExecRomney Navarro · Austin, TXExecHerbert B. Stern · Palm Beach Gardens, FLExec · DirectorDouglas B. Wolf · Palm Beach Gardens, FLExec · DirectorCorey B. Siegel · Palm Beach Gardens, FLExec · DirectorFrank B. Peabody · Palm Beach Gardens, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗